Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-α when the anti-erythropoietin antibody titer declines spontaneously

Journal of Korean Medical Science

Volumn 25, Issue 11, 2010, Pages 1676-1679

  Lee, Hajeong ^a   Yang, Jaeseok ^a   Kim, Hyosang ^a   Kwon, Ju Won ^b   Oh, Kook Hwan ^a   Joo, Kwon Wook ^a   Kim, Yon Su ^a   Ahn, Curie ^a   Han, Jin Suk ^a   Kim, Suhnggwon ^a,c  

^a Seoul National University Hospital   (South Korea)

^b Kwon's Medical Clinic   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Chronic; Darbepoetin alfa; Erythropoietin; Kidney failure; Pure; Recombinant; Red cell aplasia

Indexed keywords

ANTIANEMIC AGENT; ANTIBODY; DRUG DERIVATIVE; ERYTHROPOIETIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OXYMETHOLONE; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BLOOD; BONE MARROW CELL; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOLOGY; PATHOLOGY; PURE RED CELL ANEMIA;

ADULT; ANEMIA; ANTIBODIES; BONE MARROW CELLS; DRUG HYPERSENSITIVITY; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; GLOMERULONEPHRITIS, IGA; HEMATINICS; HUMANS; KIDNEY FAILURE, CHRONIC; OXYMETHOLONE; RED-CELL APLASIA, PURE;

EID: 78449304563     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.11.1676     Document Type: Article

References (16)

1. Weber G, Gross J, Kromminga A, Loew HH, Eckardt KU. Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with diferent epoetins. J Am Soc Nephrol 2002; 13: 2381-3.
2. Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med 1996; 334: 630-3.
3. Bennett CL, Cournoyer D, Carson KR, Rossert J, Luminari S, Evens AM, Locatelli F, Belknap SM, McKoy JM, Lyons EA, Kim B, Sharma R, Costello S, Tofelmire EB, Wells GA, Messner HA, Yarnold PR, Triflio SM, Raisch DW, Kuzel TM, Nissenson A, Lim LC, Tallman MS, Casadevall N. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood 2005; 106: 3343-7.
4. Macdougall IC, Roche A, Rossert J, Casadevall N, Francois P, Kemeny DM. Re-challenging patients who developed pure red cell aplasia with epoetin: can it be done? Nephrol Dial Transplant 2004; 19: 2901-5.
5. Yang J, Joo KW, Kim YS, Ahn C, Han JS, Kim S, Lee JS. Two cases of pure red-cell aplasia due to anti-erythropoietin antibodies. J Nephrol 2005; 18: 102-5.
6. Summers S, Holdsworth S, Sharples E. Te (re)challenging question of erythropoiesis-stimulating agents inducing pure red cell aplasia. Nephrol Dial Transplant 2008; 23: 3053-5.
7. Mandreoli M, Finelli C, Lopez A, Ascani S, Vianelli N, Baccarani M, Santoro A. Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia. Am J Kidney Dis 2004; 44: 757-61.
8. Westerlund P, Kurkus J, Segelmark M. Rapid resolution of EPO-induced pure red cell aplasia after a course of immunoadsorption therapy using protein A columns. Am J Kidney Dis 2005; 45: e97-9.
9. Pollock C, Johnson DW, Horl WH, Rossert J, Casadevall N, Schellekens H, Delage R, De Francisco A, Macdougall I, Torpe R, Tofelmire E. Pure red cell aplasia induced by erythropoiesis-stimulating agents. Clin J Am Soc Nephrol 2008; 3: 193-9.
10. Rossert J, Macdougall I, Casadevall N. Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: multiple options. Nephrol Dial Transplant 2005; 20 Suppl 4: iv23-6.
11. Vartia A, Asola MR, Tertti R, Kunelius P, Metsarinne K P. Two haemodi-alysis patients with epoetin alfa-induced pure red-cell aplasia recovered despite treatment with another epoetin preparation. Nephrol Dial Transplant 2004; 19: 1313-6.
12. Summers SA, Matijevic A, Almond MK. Successful re-introduction of re-combinant human erythropoietin following antibody induced pure red cell aplasia. Nephrol Dial Transplant 2004; 19: 2137-9.
13. Asari A, Gokal R. Pure red cell aplasia secondary to epoetin alpha responding to Darbepoetin alpha in a patient on peritoneal dialysis. J Am Soc Nephrol 2004; 15: 2204-7.
14. Viron B, Dupuy CA, Kolta A, Casadevall N. Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugs. Nephrol Dial Transplant 2008; 23: 2416-8.
15. Cournoyer D, Tofelmire EB, Wells GA, Barber DL, Barrett BJ, Delage R, Forrest DL, Gagnon R F, Harvey EA, Laneuville P, Patterson BJ, Poon MC, Posen GA, Messner HA. Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk. J Am Soc Nephrol 2004; 15: 2728-34.
16. Woodburn KW, Fan Q, Winslow S, Chen MJ, Mortensen RB, Casadevall N, Stead RB, Schatz PJ. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model. Exp Hematol 2007; 35: 1201-8.